VP5-2021: IMpower133: Gene expression (GE) analysis in long-term survivors (LTS) with ES-SCLC treated with first-line carboplatin and etoposide (CE) ± atezolizumab (atezo).

Authors :: Liu, S.V.
Mok, T.S.K.
Mansfield, A.S.
De Boer, R.H.
Losonczy, G.
Sugawara, S.
Krzakowski, M.J.
Smolin, A.
Hochmair, M.J.
Garassino, M.C.
Gay, C.M.
Heymach, J.V.
Byers, L.A.
McCleland, M.
Nabet, B.Y.
Morris, S.
Adler, L.
Shames, D.
Reck, M.
Source :: Annals of Oncology. Aug2021, Vol. 32 Issue 8, p1063-1065. 3p.
Publication Year :: 2021

Subjects :: *GENE expression
*SMALL cell lung cancer
*CARBOPLATIN
*ETOPOSIDE
*CANCER patients

Full Text Access

Tools